Literature DB >> 51878

Inhibition of macrophage-lymphocyte interaction by cytochalasin B during antigen recognition by T lymphocytes.

A S Rosenthal, J T Blake, P E Lipsky.   

Abstract

The effects of cytochalasin B on functional and physical macrophage-lymphocyte interaction have been examined. Cytochalasin B, an inhibitor of a variety of membrane activities blocks antigen-dependent bindings of immune lymphocytes to macrophages and antigen-triggered lymphocytes proliferation if added at the initiation of culture. Cytochalasin B becomes progressively less inhibitory if addition is delayed by increasing intervals from the onset of culture. Under these conditions neither antigen handling by macrophages nor the proliferative response of lymphocytes to PHA is inhibited by cytochalasin B. These data are interpreted to suggest that cytochalasin B inhibits antigen-specific macrophage-lymphocyte interaction either by inhibition of an initial antigen-independent phase of macrophage-lymphocyte interaction or by interfering with a lymphocyte membrane event necessary for the interaction of the antigen-specific lymphocyte receptor with the macrophage-bound antigenic signal.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51878

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Macrophage T-cell interaction in man: handling of tetanus toxoid antigen by human monocytes.

Authors:  S D Alpert; M E Jonsen; M D Broff; E Schneeberger; R S Geha
Journal:  J Clin Immunol       Date:  1981-01       Impact factor: 8.317

2.  Cytochalasin-B-induced immunosuppression of murine allogeneic anti-tumor response and the effect of recombinant human interleukin-2.

Authors:  D Bogyo; S R Fondy; L Finster; C Fondy; S Patil; T P Fondy
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Cytochalasin B is a potent mitogen for chronic lymphocytic leukemia cells in vitro.

Authors:  R A Larson; S Yachnin
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.